Showing results (221-230 of 650) with videos related to
Sort By:
Pageof 65
PPAR Research|October 2, 2012
The role of peroxisome proliferator-activated receptors in colorectal cancerJoo-In Park, Jong-Young KwakPPAR Research|October 24, 2012
Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunctionAna Alzamendi, Andrés Giovambattista, María E García, et al.PPAR Research|October 11, 2012
Rhein Reduces Fat Weight in db/db Mouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPARγ SignalingYu Zhang, Shengjie Fan, Na Hu, et al.PPAR Research|July 26, 2012
Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotypeHernan Sierra, Reiko Sakurai, W N Paul Lee, et al.PPAR Research|March 20, 2010
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver DiseaseJames P Hardwick, Douglas Osei-Hyiaman, Homer Wiland, et al.PPAR Research|March 20, 2010
A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle CellsJoey Z Liu, Christopher J Lyon, Willa A Hsueh, et al.PPAR Research|April 3, 2008
PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic ApproachesFiorella Malchiodi-Albedi, Andrea Matteucci, Antonietta Bernardo, et al.PPAR Research|May 10, 2008
Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in CancerCostas Giaginis, Anna Tsantili-Kakoulidou, Stamatios TheocharisPPAR Research|May 10, 2008
Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's DiseaseMahmoud KiaeiPageof 65